Stay updated on Adjunctive KarXT in Schizophrenia Clinical Trial

Sign up to get notified when there's something new on the Adjunctive KarXT in Schizophrenia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjunctive KarXT in Schizophrenia Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record history now shows a new revision, v3.5.4, added to replace the previous v3.5.3. This indicates an updated version of the study record in the history log.
    Difference
    0.1%
    Check dated 2026-05-18T04:00:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The Record History shows a new update on 2026-05-05 indicating that results have been posted and several sections were added (More Information, Outcome Measures, Participant Flow, Document Section, Study Status); a prior entry of 'Results Submitted' from 2025-03-28 was removed.
    Difference
    0.5%
    Check dated 2026-05-11T01:56:49.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Updated the page’s displayed ClinicalTrials.gov revision from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-26T08:18:39.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-19T01:32:35.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added access to core study data sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with More Information and Quality Control status.
    Difference
    0.7%
    Check dated 2026-04-11T20:32:57.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Sponsor name updated from Karuna Therapeutics to Karuna Therapeutics, Inc., a Bristol Myers Squibb company. This aligns the sponsor with current corporate ownership and ensures accurate attribution on the study record.
    Difference
    0.1%
    Check dated 2026-04-03T18:41:11.000Z thumbnail image

Stay in the know with updates to Adjunctive KarXT in Schizophrenia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjunctive KarXT in Schizophrenia Clinical Trial page.